C. Gambacorti-passerini: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Determination of α-1 Acid Glycoprotein in Patients with Ph+ Chronic Myeloid Leukemia during the First 13 Weeks of Therapy with STI571

Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, Joachim Lupberger, Matthias Holdhoff, Christine Appelt, Michaela Schwarz, Christian Müller, Carlo Gambacorti-Passerini, Uwe Platzbecker, Ragnhild Bon

Journal:

Blood Cells, Molecules, and Diseases

Year:

2002

Language:

english

File:

PDF, 95 KB

english, 2002

52

Differences between in Vivo and in Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obtained from Leukemic Patients

Carlo B. Gambacorti-Passerini, Francesca Rossi, Magda Verga, Holger Ruchatz, Rosalind Gunby, Roberta Frapolli, Massimo Zucchetti, Leonardo Scapozza, Silvia Bungaro, Lucia Tornaghi, Fabio Rossi, Pietro

Journal:

Blood Cells, Molecules, and Diseases

Year:

2002

Language:

english

File:

PDF, 312 KB

english, 2002

53

The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years

Rocco G. Piazza, Vera Magistroni, Anna Franceschino, Federica Andreoni, Lucia Tornaghi, Federica Colnaghi, Gianmarco Corneo, Enrico M. Pogliani, Carlo Gambacorti-Passerini

Journal:

Blood Cells, Molecules, and Diseases

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006

54

Bosutinib: A review of preclinical studies in chronic myelogenous leukaemia

Frank Boschelli, Kim Arndt, Carlo Gambacorti-Passerini

Journal:

European Journal of Cancer

Year:

2010

Language:

english

File:

PDF, 282 KB

english, 2010

55

A rapid method for the purification of wild-type and V804M mutant ret catalytic domain: A tool to study thyroid cancer

Elisa Sala, Luca Mologni, Sara Cazzaniga, Elena Papinutto, Carlo Gambacorti-Passerini

Journal:

International Journal of Biological Macromolecules

Year:

2006

Language:

english

File:

PDF, 322 KB

english, 2006

56

Expression, purification, and inhibition of human RET tyrosine kinase

Luca Mologni, Elisa Sala, Barbara Riva, Luca Cesaro, Sara Cazzaniga, Sara Redaelli, Oriano Marin, Nicola Pasquato, Arianna Donella-Deana, Carlo Gambacorti-Passerini

Journal:

Protein Expression and Purification

Year:

2005

Language:

english

File:

PDF, 363 KB

english, 2005

57

Decrease of resistance to imatinib in leukaemia

Carlo Gambacorti-Passerini

Journal:

Year:

2002

Language:

english

File:

PDF, 47 KB

english, 2002

58

Gynaecomastia in men with chronic myeloid leukaemia after imatinib

Carlo Gambacorti-Passerini, Lucia Tornaghi, Francesco Cavagnini, Pellegrino Rossi, Francesca Pecori-Giraldi, Luigi Mariani, Nadia Cambiaghi, Enrico Pogliani, Gianmarco Corneo, Lucio Gnessi

Journal:

Year:

2003

Language:

english

File:

PDF, 482 KB

english, 2003

59

Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells

Valentina Zuco, Rosanna Supino, Sabina C Righetti, Loredana Cleris, Edoardo Marchesi, Carlo Gambacorti-Passerini, Franca Formelli

Journal:

Year:

2002

Language:

english

File:

PDF, 145 KB

english, 2002

60

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias

Carlo B Gambacorti-Passerini, Rosalind H Gunby, Rocco Piazza, Annamaria Galietta, Roberta Rostagno, Leonardo Scapozza

Journal:

The Lancet Oncology

Year:

2003

Language:

english

File:

PDF, 2.07 MB

english, 2003

61

Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype

Licia Rivoltini, Flavio Arienti, Attilio Orazi, Graziella Cefalo, Marco Gasparini, Carlo Gambacorti-Passerini, Franca Fossati-Bellani, Giorgio Parmiani

Journal:

Cancer Immunology, Immunotherapy

Year:

1992

Language:

english

File:

PDF, 1.36 MB

english, 1992

62

Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors

Redaelli, Sara, Mologni, Luca, Rostagno, Roberta, Piazza, Rocco, Magistroni, Vera, Ceccon, Monica, Viltadi, Michela, Flynn, Daniel, Gambacorti-Passerini, Carlo

Journal:

American Journal of Hematology

Year:

2012

Language:

english

File:

PDF, 199 KB

english, 2012

63

PNAs as novel cancer therapeutics

Luca Mologni, Carlo Gambacorti-Passerini

Journal:

International Journal of Peptide Research and Therapeutics

Year:

2003

Language:

english

File:

PDF, 202 KB

english, 2003

64

Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL + leukemia stem cells

Palamà, Ilaria E, Leporatti, Stefano, Luca, Emanuela de, Renzo, Nicola Di, Maffia, Michele, Gambacorti-Passerini, Carlo, Rinaldi, Ross, Gigli, Giuseppe, Cingolani, Roberto, Coluccia, Addolorata ML

Journal:

Year:

2010

Language:

english

File:

PDF, 649 KB

english, 2010

65

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations

Meggendorfer, M, Bacher, U, Alpermann, T, Haferlach, C, Kern, W, Gambacorti-Passerini, C, Haferlach, T, Schnittger, S

Journal:

Year:

2013

Language:

english

File:

PDF, 453 KB

english, 2013

66

Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase

Mologni, Luca, Redaelli, Sara, Morandi, Andrea, Plaza-Menacho, Ivan, Gambacorti-Passerini, Carlo

Journal:

Molecular and Cellular Endocrinology

Year:

2013

Language:

english

File:

PDF, 811 KB

english, 2013

67

Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

van Etten, Richard A., Mauro, Michael, Radich, Jerald P., Goldman, John M., Saglio, Giuseppe, Jamieson, Catriona, Soverini, Simona, Gambacorti-Passerini, Carlo, Hehlmann, Rüdiger, Martinelli, Giovanni

Journal:

Leukemia and Lymphoma

Year:

2013

Language:

english

File:

PDF, 230 KB

english, 2013

68

Crizotinib in Anaplastic Large-Cell Lymphoma

Gambacorti-Passerini, Carlo, Messa, Cristina, Pogliani, Enrico M.

Journal:

Boston Medical and Surgical Journal

Year:

2011

Language:

english

File:

PDF, 476 KB

english, 2011

69

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Kantarjian, Hagop, Sawyers, Charles, Hochhaus, Andreas, Guilhot, Francois, Schiffer, Charles, Gambacorti-Passerini, Carlo, Niederwieser, Dietger, Resta, Debra, Capdeville, Renaud, Zoellner, Ulrike, Ta

Journal:

Boston Medical and Surgical Journal

Year:

2002

Language:

english

File:

PDF, 173 KB

english, 2002

70

Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors

Tardy, Sébastien, Orsato, Alexandre, Mologni, Luca, Bisson, William H., Donadoni, Carla, Gambacorti-Passerini, Carlo, Scapozza, Leonardo, Gueyrard, David, Goekjian, Peter G.

Journal:

Bioorganic & Medicinal Chemistry

Year:

2014

Language:

english

File:

PDF, 3.30 MB

english, 2014

71

Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11–12, 2013

Breccia, Massimo, Alimena, Giuliana, Baccarani, Michele, Bocchia, Monica, Di Raimondo, Francesco, Gambacorti-Passerini, Carlo, Gozzini, Antonella, Morra, Enrica, Pane, Fabrizio, Pregno, Patrizia, Rege

Journal:

Critical Reviews in Oncology/Hematology

Year:

2014

Language:

english

File:

PDF, 580 KB

english, 2014

72

O-001 Clinical and biological implications of gene mutations in MDS

Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van-Loo, P., Pellagati, A., Groves, M., Cross, N., Gambacorti-Passerini, C., Green, A., Boultwood, J., Vyas, P., Hellstrom-Lindber

Journal:

Leukemia Research

Year:

2013

Language:

english

File:

PDF, 65 KB

english, 2013

73

Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture

Mussoni, L., Conforti, G., Gambacorti-Passerini, C., Alessio, G., Pepe, S., Vaghi, M., Erba, E., Amato, G., Landoni, F., Mangioni, C.

Journal:

European Journal of Cancer and Clinical Oncology

Year:

1986

Language:

english

File:

PDF, 1.32 MB

english, 1986

74

Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

Cortes, J. E., Kim, D.-W., Kantarjian, H. M., Brummendorf, T. H., Dyagil, I., Griskevicius, L., Malhotra, H., Powell, C., Gogat, K., Countouriotis, A. M., Gambacorti-Passerini, C.

Journal:

Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 161 KB

english, 2012

75

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia

Gambacorti-Passerini, Carlo, Cortes, Jorge E., Lipton, Jeff H., Dmoszynska, Anna, Wong, Raymond S., Rossiev, Victor, Pavlov, Dmitri, Gogat Marchant, Karin, Duvillié, Ladan, Khattry, Navin, Kantarjian,

Journal:

American Journal of Hematology

Year:

2014

Language:

english

File:

PDF, 417 KB

english, 2014

76

A Mechanistic Design Principle for Protein Tyrosine Kinase Sensors: Application to a Validated Cancer Target

Wakata, Aya, Cahill, Sean M., Blumenstein, Michael, Gunby, Rosalind H., Jockusch, Steffen, Marti, Angel A., Cimbro, Barbara, Gambacorti-Passerini, Carlo, Donella-Deana, Arianna, Pinna, Lorenzo A., Tur

Journal:

Organic Letters

Year:

2008

Language:

english

File:

PDF, 142 KB

english, 2008

77

Unique Substrate Specificity of Anaplastic Lymphoma Kinase (ALK): Development of Phosphoacceptor Peptides for the Assay of ALK Activity †

Donella-Deana, Arianna, Marin, Oriano, Cesaro, Luca, Gunby, Rosalind H., Ferrarese, Anna, Coluccia, Addolorata M. L., Tartari, Carmen J., Mologni, Luca, Scapozza, Leonardo, Gambacorti-Passerini, Carlo

Journal:

Year:

2005

Language:

english

File:

PDF, 192 KB

english, 2005

78

Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RAR Protein in Acute Promyelocytic Leukemia Cells

Shao, W., Fanelli, M., Ferrara, F. F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W. W., Waxman, S., Pelicci, P. G., Lo Coco, F., Avvisati, G., Testy, U., Peschle, C., Gambacorti-Passerini, C.,

Journal:

JNCI Journal of the National Cancer Institute

Year:

1998

Language:

english

File:

PDF, 361 KB

english, 1998

79

BRAF Silencing by Short Hairpin RNA or Chemical Blockade by PLX4032 Leads to Different Responses in Melanoma and Thyroid Carcinoma Cells

Sala, E., Mologni, L., Truffa, S., Gaetano, C., Bollag, G. E., Gambacorti-Passerini, C.

Journal:

Molecular Cancer Research

Year:

2008

Language:

english

File:

PDF, 388 KB

english, 2008

80

ALK a Novel Lymphoma-associated Tumor Antigen for Vaccination Strategies

Passoni, Lorena, Gambacorti-Passerini, Carlo

Journal:

Leukemia and Lymphoma

Year:

2003

Language:

english

File:

PDF, 146 KB

english, 2003

81

Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors

Kantarjian, H. M., Cortes, J. E., Kim, D.-W., Khoury, H. J., Brummendorf, T. H., Porkka, K., Martinelli, G., Durrant, S., Leip, E., Kelly, V., Turnbull, K., Besson, N., Gambacorti-Passerini, C.

Journal:

Year:

2014

Language:

english

File:

PDF, 321 KB

english, 2014

82

How I treat newly diagnosed chronic myeloid leukemia in 2015

Gambacorti-Passerini, Carlo, Piazza, Rocco

Journal:

American Journal of Hematology

Year:

2015

Language:

english

File:

PDF, 723 KB

english, 2015

83

The Role of the Immune System in Anti-Tumour Responses

Said Dermime,John Barrett,Dr Carlo Gambacorti-Passerini

Journal:

Year:

1995

Language:

english

File:

PDF, 2.07 MB

english, 1995

84

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, Carlo, Brümmendorf, Tim H., Kim, Dong-Wook, Turkina, Anna G., Masszi, Tamas, Assouline, Sarit, Durrant, Simon, Kantarjian, Hagop M., Khoury, H. Jean, Zaritskey, Andrey, Shen, Zhi

Journal:

American Journal of Hematology

Year:

2014

Language:

english

File:

PDF, 910 KB

english, 2014

85

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

Spinelli, Roberta, Pirola, Alessandra, Redaelli, Sara, Sharma, Nitesh, Raman, Hima, Valletta, Simona, Magistroni, Vera, Piazza, Rocco, Gambacorti-Passerini, Carlo

Journal:

Molecular Genetics & Genomic Medicine

Year:

2013

Language:

english

File:

PDF, 2.89 MB

english, 2013

86

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

Spinelli, Roberta, Pirola, Alessandra, Redaelli, Sara, Sharma, Nitesh, Raman, Hima, Valletta, Simona, Magistroni, Vera, Piazza, Rocco, Gambacorti-Passerini, Carlo

Journal:

Molecular Genetics & Genomic Medicine

Year:

2014

Language:

english

File:

PDF, 430 KB

english, 2014

87

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

Brümmendorf, Tim H., Cortes, Jorge E., de Souza, Cármino Antonio, Guilhot, Francois, Duvillié, Ladan, Pavlov, Dmitri, Gogat, Karïn, Countouriotis, Athena M., Gambacorti-Passerini, Carlo

Journal:

British Journal of Haematology

Year:

2015

Language:

english

File:

PDF, 333 KB

english, 2015

88

Acute Promyelocytic Leukaemia Cells Resistant to Retinoic Acid Show Further Perturbation of the RARα Signal Transduction System

Dermime, Said, Grignani, Francesco, Rogaia, Daniela, Liberatore, Concetta, Marchesi, Edoardo, Gambacorti-Passerini, Carlo

Journal:

Leukemia and Lymphoma

Year:

1995

Language:

english

File:

PDF, 614 KB

english, 1995

89

New developments in the treatment of ALK-driven malignancies

Mologni, Luca, Gambacorti-Passerini, Carlo

Journal:

Clinical Investigation

Year:

2012

Language:

english

File:

PDF, 836 KB

english, 2012

90

Characterization of Some Molecular Mechanisms Governing Autoactivation of the Catalytic Domain of the Anaplastic Lymphoma Kinase

Tartari, C. J., Gunby, R. H., Coluccia, A. M. L., Sottocornola, R., Cimbro, B., Scapozza, L., Donella-Deana, A., Pinna, L. A., Gambacorti-Passerini, C.

Journal:

Journal of Biological Chemistry

Year:

2008

Language:

english

File:

PDF, 401 KB

english, 2008

91

Sorafenib functions to potently suppress RET tyrosine kinase activity by direct enzymatic inhibition and promoting RET lysosomal degradation independent of proteasomal targeting.

Plaza-Menacho, I., Mologni, L., Sala, E., Gambacorti-Passerini, C., Magee, A. I., Links, T. P., Hofstra, R. M. W., Barford, D., Isacke, C. M.

Journal:

Journal of Biological Chemistry

Year:

2009

Language:

english

File:

PDF, 519 KB

english, 2009

92

Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting

Plaza-Menacho, I., Mologni, L., Sala, E., Gambacorti-Passerini, C., Magee, A. I., Links, T. P., Hofstra, R. M. W., Barford, D., Isacke, C. M.

Journal:

Journal of Biological Chemistry

Year:

2007

Language:

english

File:

PDF, 1.06 MB

english, 2007

93

Reply to P. Laneuville et al

Gambacorti-Passerini, C., Piazza, R., Perini, P., Rostagno, R., Redaelli, S.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

94

Development of c-Kit-expressing Small-Cell Lung Cancer in a Chronic Myeloid Leukemia Patient During Imatinib Treatment

Gambacorti-Passerini, C., Piazza, R., Tornaghi, L., Pilotti, S., Pogliani, E.

Journal:

JNCI Journal of the National Cancer Institute

Year:

2004

Language:

english

File:

PDF, 128 KB

english, 2004

95

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

le Coutre, P., Mologni, L., Cleris, L., Marchesi, E., Buchdunger, E., Giardini, R., Formelli, F., Gambacorti-Passerini, C.

Journal:

JNCI Journal of the National Cancer Institute

Year:

1999

Language:

english

File:

PDF, 183 KB

english, 1999

96

Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients

Passoni, L., Longo, L., Collini, P., Coluccia, A. M. L., Bozzi, F., Podda, M., Gregorio, A., Gambini, C., Garaventa, A., Pistoia, V., Del Grosso, F., Tonini, G. P., Cheng, M., Gambacorti-Passerini, C.

Journal:

Cancer Research

Year:

2009

Language:

english

File:

PDF, 549 KB

english, 2009

97

FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery

Piazza, R., Pirola, A., Spinelli, R., Valletta, S., Redaelli, S., Magistroni, V., Gambacorti-Passerini, C.

Journal:

Nucleic Acids Research

Year:

2012

Language:

english

File:

PDF, 4.57 MB

english, 2012

98

Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma

Ceccon, M., Mologni, L., Giudici, G., Piazza, R., Pirola, A., Fontana, D., Gambacorti-Passerini, C.

Journal:

Molecular Cancer Research

Year:

2015

Language:

english

File:

PDF, 1.04 MB

english, 2015

99

Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants

Redaelli, S., Piazza, R., Rostagno, R., Magistroni, V., Perini, P., Marega, M., Gambacorti-Passerini, C., Boschelli, F.

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 207 KB

english, 2008

100

Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients

Galvan, A., Frullanti, E., Anderlini, M., Manenti, G., Noci, S., Dugo, M., Ambrogi, F., De Cecco, L., Spinelli, R., Piazza, R., Pirola, A., Gambacorti-Passerini, C., Incarbone, M., Alloisio, M., Tosi,

Journal:

Year:

2013

Language:

english

File:

PDF, 963 KB

english, 2013